Benign Prostatic Hyperplasia Treatment Devices Market Analysis, Size, Growth and Forecast, 2023

The global benign prostatic hyperplasia treatment devices market is expected to experience an extensive growth in the coming years due to various factors such as increasing aging population, rising prevalence of benign prostatic hyperplasia, increasing awareness about benign prostatic hyperplasia treatment procedures and surge in the adoption of minimally invasive procedures. BPH devices have been classified on the basis of different procedures for which these are used such as, transurethral resection of the prostate (TURP), transurethral incision of the prostate (TUIP); laser based procedures such as green light lasers, holmium lasers, thulium lasers surgery; and energy-based procedures such as transurethral microwave thermotherapy (TUMT), transurethral needle ablation (TUNA), high-intensity focused ultrasound (HIFU) & water-induced thermotherapy; and other procedures.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/bph-treatment-devices-market/report-sample

Laser based procedures are expected to register the fastest growth in the benign prostatic hyperplasia treatment devices market during the forecast period, since these procedures are as effective as surgical procedures, reduce the hospital stay time and do not leave any scars post treatment. Benign prostatic hyperplasia refers to the enlargement of the prostate gland which obstructs the passage of urine through urethra in men. The disease is more common in aging men, and about half of all men between the age of 51 to 60 years suffer from the disease.

Growing aging population, rising prevalence of benign prostatic hyperplasia, rise in the awareness about various benign prostatic hyperplasia disorders and surge in the adoption of minimally invasive procedures are the some of the major factors driving the demand for benign prostatic hyperplasia treatment devices.

According to the United Nations Department of Economic and Social Affairs (UNDESA) report on the global aging population, the number of people aged 60 years or above is growing at a high rate and is projected to grow from 901 million in 2015 to 1.4 billion by 2030. According to the National Institute of Health, around 14 million men in the U.S. had symptoms suggestive of benign prostatic hyperplasia, which can affect 50% of men aged between 51 and 60 years of age, and up to 90% of men aged more than 80 years. With the aging population, the prevalence of benign prostatic hyperplasia is likely to increase, further leading to the rise in the demand for benign prostatic hyperplasia treatment devices.

Explore Report at: https://www.psmarketresearch.com/market-analysis/bph-treatment-devices-market

The key companies in the benign prostatic hyperplasia treatment devices industry are launching various products and are expanding in various geographies to gain a larger share in the benign prostatic hyperplasia treatment devices market.

In March 2017, NeoTract Inc. announced the expansion of its minimally invasive procedure device, UroLift System, to be available in Ireland. The geographical expansion of the product in Ireland was supported by Vhi group, a private health insurance firm. In June 2017, Olympus Corporation announced the expansion of its PLASMA Resection in Africa that provides clinical benefits and cost saving procedure, in comparison to monopolar TURP.In September 2016, NeoTract, Inc. announced that the company has received the de novo approval from USFDA for its UroLift System for prostate implant.

About P&S Market Research

P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.

With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.

Contact:
P&S Market Research
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
US/ Canada Toll-Free: 1-888-778-7886
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.